Evaluation of the Anti-inflammatory Effects of Atorvastatin on Patients with Rheumatoid Arthritis: A Randomized Clinical Trial
Journal Title: Electronic Physician - Year 2016, Vol 8, Issue 8
Abstract
BACKGROUND: Rheumatoid arthritis (RA) is a chronic inflammatory joint disorder with unknown etiology. Atorvastatin is a lipid-lowering agent that affects the inflammatory processes. OBJECTIVE: This study aimed to determine the anti-inflammatory effects of atorvastatin on the Disease Activity Index and high-density lipoprotein (HDL) concentrations in RA patients. METHODS: This clinical trial was performed on 38 RA patients, who were referred to the Imam Reza and Ghaem Medical Centers of Mashhad, Iran between 2013 and 2014. Patients were divided into two groups: 1) the intervention group, which received 40 mg of atorvastatin, and 2) the control group. Response to treatment and the clinical status of patients were evaluated using the Disease Activity Score (DAS-28) and Visual Analogue Scale (VAS) at weeks zero, four, eight, and twelve, based on the 2010 ACR/EULAR Criteria by two rheumatologists. Disease activity and laboratory parameters, including erythrocyte sedimentation rate (ESR), high-sensitivity C-reactive protein (hs-CRP), DAS-ESR, DAS- hs-CRP, high-density lipoprotein (HDL), low-density lipoprotein (LDL), and liver function test (LFT) were measured in both groups. RESULTS: There was a significant difference in the mean number of swollen joints (p<0.011), ESR (p <0.005), DAS-ESR (P<0.043), LDL (0.036), and HDL (0.016) between the two groups. The changes in trend showed no significant difference in the mean number of tender joints (p =0.38), VAS (p =0.715), CRP (p =0.07), DAS-hs-CRP (p=0.431), total cholesterol (p=0.285), or TG (p =0.331) between the two groups. However, the Disease Activity Index decreased by 48.4% in the intervention group, compared to 35.5% in the control group. CONCLUSION: As the results indicated, atorvastatin has a positive effect on the course of RA. In fact, atorvastatin, as an anti-inflammatory agent, could significantly influence inflammation in RA patients. Therefore, adding a lipid-lowering agent to standard medications in RA may be warranted and could decrease disease activity. CLINICAL TRIAL REGISTRATION: The trial was registered at the Iranian Registry of Clinical Trials (Website: http://www.irct.ir, Irct ID: IRCT2015122425648N2). FUNDING: The authors received no financial support for the research, authorship, and/or publication of this article
Authors and Affiliations
Sarabi ZS, Saeidi MG, Khodashahi M, Rezaie AE, Hashemzadeh K, Heidari H
Keywords
Related Articles
- EP ID EP328737
- DOI 10.19082/2700
- Views 67
- Downloads 0
Use of the Finnish method to quantify the ergonomic properties in an office environment among the workplaces in an Electricity Distribution Company in West Tehran Province
Introduction: The workplace plays an important role in workers’ performances, but most workplaces have not been designed and equipped in keeping with primary ergonomic principles. Ignoring these principles can cause ergo...
Effect of Maintenance Therapy with Isoxsuprine in the Prevention of Preterm Labor: Randomized controlled trial.
Isoxsuprine (Vasodilan) is a beta-adrenergic that directly affects the vascular smooth muscle and results in peripheral vascular dilation. Isoxsuprine relaxes the uterine smooth muscles and is used for treatment of pre-t...
HIV/AIDS Knowledge and attitudes of Southern Iranian students
This study aimed to explore Iranian primary school students’ attitudes and knowledge about HIV/AIDS. The knowledge and attitudes of 597 primary school students from all areas of Ahwaz were assessed by anonymous questionn...
Assessment of two hemispherical and hemispherical-conical miniature sources used in electronic brachytherapy using Monte Carlo Simulation
INTRODUCTION: Since the heart of the electronic brachytherapy system is a tube of a miniature x-ray and due to the increasing use of electronic brachytherapy, there is an urgent need for acquiring knowledge about the X-r...
Molecular typing of uropathogenic E. coli strains by the ERIC-PCR method
INTRODUCTION: Escherichia coli (E. coli) is the most common cause of urinary infections in hospitals. The aim of this study was to evaluate the ERIC-PCR method for molecular typing of uropathogenic E. coli strains isolat...